MX2009003741A - Composiciones liquidas de calcogenuro y metodos para fabricar y utilizar las mismas. - Google Patents

Composiciones liquidas de calcogenuro y metodos para fabricar y utilizar las mismas.

Info

Publication number
MX2009003741A
MX2009003741A MX2009003741A MX2009003741A MX2009003741A MX 2009003741 A MX2009003741 A MX 2009003741A MX 2009003741 A MX2009003741 A MX 2009003741A MX 2009003741 A MX2009003741 A MX 2009003741A MX 2009003741 A MX2009003741 A MX 2009003741A
Authority
MX
Mexico
Prior art keywords
manufacturing
methods
same
chalcogenide compositions
compositions
Prior art date
Application number
MX2009003741A
Other languages
English (en)
Inventor
Edward Wintner
Thomas L Deckwerth
Kevin J Tomaselli
Paul A Hill
Csaba Szabo
Original Assignee
Ikaria Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ikaria Inc filed Critical Ikaria Inc
Publication of MX2009003741A publication Critical patent/MX2009003741A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

La presente invención proporciona composiciones líquidas estables, novedosas, que comprenden calcogenuros o sales de los mismos; estas composiciones pueden utilizarse para una variedad de propósitos, incluyendo el tratamiento y prevención de la lesión isquémica o hipóxica, así como en la conservación de materia biológica.
MX2009003741A 2006-10-05 2007-10-05 Composiciones liquidas de calcogenuro y metodos para fabricar y utilizar las mismas. MX2009003741A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84990006P 2006-10-05 2006-10-05
US89672707P 2007-03-23 2007-03-23
PCT/US2007/080613 WO2008043081A2 (en) 2006-10-05 2007-10-05 Liquid chalcogenide compositions and methods of manufacturing and using the same

Publications (1)

Publication Number Publication Date
MX2009003741A true MX2009003741A (es) 2009-07-10

Family

ID=39149128

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009003741A MX2009003741A (es) 2006-10-05 2007-10-05 Composiciones liquidas de calcogenuro y metodos para fabricar y utilizar las mismas.

Country Status (13)

Country Link
US (1) US20080187604A1 (es)
EP (1) EP2068893A2 (es)
JP (1) JP5303465B2 (es)
KR (2) KR101538727B1 (es)
CN (1) CN101534844B (es)
AU (1) AU2007303050B2 (es)
BR (1) BRPI0719539A2 (es)
CA (1) CA2664341C (es)
HK (1) HK1132905A1 (es)
IL (1) IL197945A (es)
MX (1) MX2009003741A (es)
NZ (1) NZ575671A (es)
WO (1) WO2008043081A2 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1879599B1 (en) * 2005-04-20 2013-10-16 Fred Hutchinson Cancer Research Center Methods, compositions and articles of manufacture for enhancing survivability of cells, tissues, organs, and organisms
US20100143503A1 (en) * 2006-12-22 2010-06-10 Ikaria, Inc. Combinations of nitric oxide and sulfide and methods of use and manufacture thereof
US20100247680A1 (en) * 2007-06-15 2010-09-30 Csaba Szabo Compositions and Methods to Modulate Angiogenesis
EP2170356A1 (en) * 2007-06-25 2010-04-07 Fred Hutchinson Cancer Research Center Methods and compositions regarding polychalcogenide compositions
US20100183748A1 (en) 2009-01-21 2010-07-22 Ikaria, Inc. Methods for Treating or Preventing Radiocontrast Agent Induced Kidney Injury
US20100198338A1 (en) * 2009-01-30 2010-08-05 Medtronic Vascular, Inc., A Delaware Corporation Hydrogen Sulfide Donating Polymers
US8541396B2 (en) 2009-04-24 2013-09-24 National University Of Singapore Morpholin-4-ium 4 methoxyphenyl (morpholino) phosphinodithioate (GYY4137) as a novel vasodilator agent
WO2011079222A2 (en) 2009-12-23 2011-06-30 Boston Scientific Scimed, Inc. Less traumatic method of delivery of mesh-based devices into human body
US8182830B2 (en) * 2010-01-05 2012-05-22 Medtronic Vascular, Inc. Hydrogen sulfide generating polymers
US9518950B2 (en) * 2011-08-19 2016-12-13 Northeastern University Chemical sensor based on highly organized single walled carbon nanotube networks
CA2875212A1 (en) * 2012-06-13 2013-12-19 Fred Hutchinson Cancer Research Center Compositions comprising chalcogenides and related methods
TW201420130A (zh) * 2012-09-26 2014-06-01 Neochemir Inc 溶解有二氧化碳之液狀藥劑及其投藥方法
CN104981151A (zh) * 2012-12-31 2015-10-14 索玛解有限公司 具有增加的稳定性及储存寿命的器官及组织保存的配制物
JP2014201580A (ja) * 2013-04-10 2014-10-27 株式会社昭和冷凍プラント 窒素水を用いた移植臓器の保存用又は洗浄用の処理液及びその調製方法
JP6573620B2 (ja) 2014-02-10 2019-09-11 フレッド ハッチンソン キャンサー リサーチ センター 心臓発作及び虚血損傷のハロゲン治療
EP3288893B8 (de) * 2015-04-29 2019-04-10 BSN medical GmbH Mehrstufiges verfahren zur no-herstellung
CN106539818A (zh) * 2015-09-20 2017-03-29 复旦大学 硫化氢及其供体硫氢化钠在制备促造血药物中的用途
CN105964217B (zh) * 2016-06-17 2018-10-12 中国科学院城市环境研究所 一种磁性KMS-1/Fe3O4复合材料的制备方法及其用于去除环丙沙星
EP3299021A1 (en) * 2016-09-21 2018-03-28 Universitätsklinikum Jena Thiosulfate for treating hepatic ischemia/reperfusion injury
ES2965705T3 (es) * 2017-02-09 2024-04-16 Noxsano Inc Composiciones generadoras de gasotransmisor electroquímico y métodos de utilización de las mismas, y apósitos y sistemas de tratamiento que las incorporan
WO2019036722A1 (en) 2017-08-18 2019-02-21 Northeastern University METHOD FOR PRODUCING TETRATENITE AND SYSTEM THEREOF
EP3684436A1 (en) 2017-09-22 2020-07-29 Becton, Dickinson and Company 4% trisodium citrate solution for use as a catheter lock solution
US20220105126A1 (en) * 2020-10-02 2022-04-07 Craig Mercer Boulris Composition for preventing and treating microbial disease
US11679119B2 (en) 2021-09-24 2023-06-20 MAIA Pharmaceuticals, Inc. Bortezomib compositions
CN115040648B (zh) * 2022-06-02 2023-07-28 中山大学 一种基于硫化氢促进钙超载协同光热特异性治疗肿瘤的纳米粒及其制备方法
CN116804630B (zh) * 2023-08-03 2024-03-05 中拓生物有限公司 一种血清同型半胱氨酸测定试剂盒

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364555A (en) 1991-04-30 1994-11-15 Advanced Oxygen Technologies, Inc. Polymer compositions containing salicylic acid chelates as oxygen scavengers
US6458758B1 (en) 1993-08-16 2002-10-01 Synzyme Technologies, Inc. Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
AU5620598A (en) 1996-12-31 1998-07-31 Antioxidant Pharmaceuticals Corporation Pharmaceutical preparations of glutathione and methods of administration thereof
EP2363022A3 (en) 2003-10-22 2011-12-21 Fred Hutchinson Cancer Research Center Use of oxygen antagonists for the therapeutic treatment of mammals
US20050106214A1 (en) 2003-11-14 2005-05-19 Guohua Chen Excipients in drug delivery vehicles
EP1879599B1 (en) * 2005-04-20 2013-10-16 Fred Hutchinson Cancer Research Center Methods, compositions and articles of manufacture for enhancing survivability of cells, tissues, organs, and organisms
WO2006119258A2 (en) * 2005-04-29 2006-11-09 University Of Houston Use of hydrogen sulfide in the treatment of eye diseases
CA2646674A1 (en) * 2006-04-20 2007-11-01 Fred Hutchinson Cancer Research Center Use of chalcogenides for treating shock and other adverse conditions

Also Published As

Publication number Publication date
KR101538727B1 (ko) 2015-07-22
CN101534844B (zh) 2014-04-23
IL197945A (en) 2016-12-29
NZ575671A (en) 2011-04-29
JP5303465B2 (ja) 2013-10-02
JP2010505879A (ja) 2010-02-25
WO2008043081A2 (en) 2008-04-10
CN101534844A (zh) 2009-09-16
KR20090086210A (ko) 2009-08-11
CA2664341C (en) 2018-11-06
BRPI0719539A2 (pt) 2014-01-14
EP2068893A2 (en) 2009-06-17
CA2664341A1 (en) 2008-04-10
IL197945A0 (en) 2009-12-24
KR20150042291A (ko) 2015-04-20
US20080187604A1 (en) 2008-08-07
HK1132905A1 (en) 2010-03-12
AU2007303050A1 (en) 2008-04-10
AU2007303050B2 (en) 2013-11-07
WO2008043081A3 (en) 2008-05-29

Similar Documents

Publication Publication Date Title
MX2009003741A (es) Composiciones liquidas de calcogenuro y metodos para fabricar y utilizar las mismas.
HK1137366A1 (en) Pharmaceutical compositions comprising activin-actriia antagonists and use thereof in preventing or treating multiple myeloma
WO2006107451A3 (en) Honokiol derivatives for the treatment of proliferative disorders
MX2009000285A (es) Piperidinas sustituidas que incrementan la actividad de p53 y usos de las mismas.
WO2007146965A3 (en) Compounds for the treatment of periodontal disease
WO2009077471A3 (de) Azolylmethyloxirane, ihre verwendung sowie sie enthaltende mittel
UA105778C2 (uk) Піразол-4-n-алкоксикарбоксаміди як мікробіоциди, композиція, що їх містить, та спосіб боротьби із зараженням корисних рослин фітопагенними мікроорганізмами або його попередження з їх використанням
WO2007064872A3 (en) Urea compounds useful in the treatment of cancer
IL196543A (en) Pyridazinone derivatives, pharmaceutical preparations containing them for use in the treatment of disorders
WO2006116221A3 (en) Therapeutic combinations for the treatment or prevention of psychotic disorders
TW200621268A (en) Antimicrobial copolymers and uses thereof
IL198626A0 (en) Core-1 positive microorganisms, compositions containing the same and methods of use thereof
BRPI0909447A2 (pt) Composição, métodos para tratar um indivíduo humano ou animal em necessidade de tal tratamento e para matar ou inibir o crescimento de microrganismos suscetíveis, e, uso de uma composição
TW200740799A (en) Alpha2C adrenoreceptor agonists
WO2004062613A3 (en) Hiv integrase inhibitors
WO2007124447A3 (en) Use of chalcogenides for treating shock and other adverse conditions
MY148723A (en) Use of pinolenic acid for the treatment of obesity
WO2007067559A3 (en) Antibacterial agents
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
WO2008049042A3 (en) Ophthalmic compositions containing diglycine
WO2007067519A3 (en) The use of neurotransmitters and neuropeptides for the treatment of dry eye diseases and related conditions
WO2009041014A1 (ja) コンベア用除菌性潤滑剤組成物およびその使用方法
WO2008132021A3 (de) Fungizide mischungen
MXPA05012929A (es) Productos aril-heteroaromaticos, composiciones que los contienen y su utilizacion.
WO2007006521A3 (en) Nutritional mixtures with a high and increased efficacy

Legal Events

Date Code Title Description
FG Grant or registration